Factors Influencing Utilization of Different Types of Sulphonylureas Amongst Type 2 Diabetes Patients

被引：0
|
作者：
Huri, Hasniza Z. [1 ]
Wei, Amy T. -L. [1 ]
Pendek, Rokiah [2 ]
Sulaiman, Che Z. [3 ]
Widodo, Riyanto T. [1 ]
机构：
[1] Univ Malaya, Dept Pharm, Kuala Lumpur 50603, Malaysia
[2] Univ Malaya, Dept Med, Fac Med, Kuala Lumpur 50603, Malaysia
[3] Univ Malaya, Med Ctr, Pharm Unit, Kuala Lumpur, Malaysia
来源：
LATIN AMERICAN JOURNAL OF PHARMACY | 2010年 / 29卷 / 06期
关键词：
Glibenclamide; Gliclazide; Glipizide; Sulphonylureas; Type 2 diabetes mellitus; OLDER PERSONS; INSULIN; HYPOGLYCEMIA; MELLITUS; FAILURE;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Sulphonylureas (SUs) are commonly prescribed in Malaysia and also worldwide. However, very limited information is available on their pattern of use and appropriateness of its utilization. Age, concurrent use of drugs such as beta blocker, salicylate and frusemide and also renal impairment were found to have influence on the selection of different types of SUs.
引用
收藏
页码：1044 / 1048
页数：5
相关论文
共 50 条
  • [21] Factors influencing insulinotherapy results in type 2 diabetes
    Zantour, B.
    Sfari, N.
    Alaya, W.
    Chebbi, W.
    Bouzidi, H.
    Sfar, M. Habib
    DIABETES & METABOLISM, 2012, 38 : A110 - A110
  • [22] Renal impairment markers in type 2 diabetes patients with different types of hyperuricemia
    Gao, Zhongai
    Zuo, Minxia
    Han, Fei
    Yuan, Xinxin
    Sun, Mengdi
    Li, Xiaochen
    Liu, Ran
    Jiang, Wenhui
    Zhang, Liyi
    Chang, Baocheng
    Yang, Juhong
    JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (01) : 118 - 123
  • [23] Adherence to Medication, Diet and Physical Activity and the Associated Factors Amongst Patients with Type 2 Diabetes
    Alireza Mirahmadizadeh
    Haniyeh Khorshidsavar
    Mozhgan Seif
    Mohammad Hossein Sharifi
    Diabetes Therapy, 2020, 11 : 479 - 494
  • [24] Adherence to Medication, Diet and Physical Activity and the Associated Factors Amongst Patients with Type 2 Diabetes
    Mirahmadizadeh, Alireza
    Khorshidsavar, Haniyeh
    Seif, Mozhgan
    Sharifi, Mohammad Hossein
    DIABETES THERAPY, 2020, 11 (02) : 479 - 494
  • [25] IL-12 serum levels in patients with type 2 diabetes treated with sulphonylureas
    Wegner, Malgorzata
    Winiarska, Hanna
    Bobkiewicz-Kozlowska, Teresa
    Dworacka, Marzena
    CYTOKINE, 2008, 42 (03) : 312 - 316
  • [26] Effectiveness of sulphonylureas in the therapy of diabetes mellitus type 2 patients: An observational cohort study
    Wilke T.
    Mueller S.
    Groth A.
    Berg B.
    Hammar N.
    Tsai K.
    Fuchs A.
    Stephens S.
    Maywald U.
    Journal of Diabetes & Metabolic Disorders, 15 (1):
  • [27] Factors associated with switching from sulphonylureas to dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in the United States
    Tan, Xi
    Yang, Lingfeng
    Khunti, Kamlesh
    Zhang, Ruya
    Zhang, Ye
    Rajpathak, Swapnil
    Yu, Miao
    DIABETES OBESITY & METABOLISM, 2021, 23 (10): : 2251 - 2260
  • [28] Glycemic control and its influencing factors in type 2 diabetes patients in Anhui, China
    Xing, Xiu-Ya
    Wang, Xin-Yi
    Fang, Xi
    Xu, Jing-Qiao
    Chen, Ye-Ji
    Xu, Wei
    Wang, Hua-Dong
    Liu, Zhi-Rong
    Tao, Sha-Sha
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [29] Factors influencing the prescription of physical activity in the therapeutic management of patients with type 2 diabetes
    Rousseau, Anne-Sophie
    NUTRITION CLINIQUE ET METABOLISME, 2014, 28 (04): : 310 - 320
  • [30] FACTORS INFLUENCING PATIENTS' ABILITY TO SELF-MANAGE AND CONTROL TYPE 2 DIABETES
    Santillan, Yeriko
    Goldberg, Tamara
    Olushoga, Olufunke
    Mack, Theresa
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (SUPPL 1) : S649 - S650
12345